Weight Management Services

The procurement process for "Weight Management Services" has been completed by the NHS Nottingham and Nottinghamshire Integrated Care Board, focusing on prescribing tirzepatide (Mounjaro®) within primary care for weight management. This initiative falls under the Health Services category, with delivery planned from 1 July 2025 to 30 June 2026. The contract, valued at £206,400, was awarded to Nottingham City General Practice Alliance (NCGPA) under urgent circumstances due to the NICE publication of TA1026.

The procurement method was limited, avoiding the usual call for competition due to the urgent nature of the requirement, and thus falls outside the scope of the Procurement Act 2023. This tender offers significant opportunities for businesses involved in healthcare services, particularly those specialising in weight management and pharmaceuticals. It is an attractive opportunity for large organisations capable of delivering healthcare services across multiple regions, namely UKF14, UKF15, and UKF16.

By addressing immediate risks to safety and quality of care, suppliers involved in such contracts can enhance their reputation and strengthen relationships within the health care sector. Organisations with expertise in face-to-face assessments and ongoing management could find this contract particularly beneficial for gaining further exposure and establishing themselves as leaders in the field.